Liberty Biopharma Inc (CVE:LTY – Get Free Report) shares crossed above its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$2.00 and traded as high as C$2.00. Liberty Biopharma shares last traded at C$2.00, with a volume of 700 shares.
Liberty Biopharma Stock Up ∞
The company has a fifty day moving average of C$2.00 and a two-hundred day moving average of C$2.00. The company has a market cap of C$21.54 million and a PE ratio of -12.66. The company has a debt-to-equity ratio of 8.19, a quick ratio of 0.12 and a current ratio of 0.12.
About Liberty Biopharma
Liberty Biopharma Inc, a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of an automated bioprocessing and cell isolation technology. Its technology is used in the isolation of regenerative cells from human adipose tissues for use in research, cosmetic and aesthetic medicine, burn management, wound management and non-healing wounds, cardiovascular and heart diseases, peripheral arterial disease, critical limb ischemia or diabetic leg, and hepatic disease and kidney disease.
Featured Articles
- Five stocks we like better than Liberty Biopharma
- How to Calculate Options Profits
- The Charles Schwab Company Can Hit New Highs
- Stock Market Sectors: What Are They and How Many Are There?
- Costco vs. Walmart: Revenue Comparison of Two Retail Giants
- EV Stocks and How to Profit from Them
- 3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
Receive News & Ratings for Liberty Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liberty Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.
